$6.35 +0.07 (1.11%)

Immucell Corp (ICCC)

Immucell Corporation (ICCC) specializes in the development, manufacture, and marketing of dairy and beef cattle diagnostics, primarily focusing on products that enhance reproductive health and management in livestock. The company's offerings include herd management tools and diagnostic tests designed to improve productivity and efficiency for dairy and beef producers.

đźš« Immucell Corp does not pay dividends

Company News

ImmuCell Q2 Profit Jumps as Margins Rise
The Motley Fool • Na • August 15, 2025

ImmuCell reported Q2 2025 results with improved gross margins and completed First Defense production capacity expansion, but faces ongoing FDA approval delays for Retain product, creating uncertainty in near-term growth trajectory.

PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Benzinga • Avi Kapoor • July 10, 2024

The article discusses several stocks to watch heading into Wednesday, including PriceSmart, Kura Sushi, Manchester United, ImmuCell, and AZZ Inc. It provides details on the expected earnings and stock price movements for these companies.

ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
GlobeNewswire Inc. • ImmuCell Corporation • June 5, 2024

PORTLAND, Maine , June 05, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today provided a regulatory upda...